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Porcine reproductive and respiratory syndrome virus (PRRSV) is an arterivirus that emerged in the
late 1980s in both Europe and North America as the causative agent of porcine reproductive and
respiratory syndrome (PRRS), now the most important disease of swine worldwide. Despite
extensive characterization of PRRSV proteins by direct analysis and comparison with other
arteriviruses, determinants of virulence, pathogenesis and protective immune recognition remain
poorly understood. Thus, we hypothesized that additional ORFs are present in the PRRSV
genome that may contribute to its biological properties, and so we screened highly purified virions
of strain VR2332, the prototype type 2 PRRSV, for evidence of novel polypeptides. A 51 aa
polypeptide was discovered that is encoded by an alternative ORF of the subgenomic mRNA
encoding the major envelope glycoprotein, GP5, and which is incorporated into virions. The
protein, referred to as ORF5a protein, is expressed in infected cells, and pigs infected with
PRRSV express anti-ORF5a protein antibodies. A similar ORF is present as an alternative reading
frame in all PRRSV subgenomic RNA5 genes and in all other arteriviruses, suggesting that this
ORF5a protein plays a significant role in arterivirology. Its discovery also provides a new potential
target for immunological and pharmacological intervention in PRRS.
INTRODUCTION
Porcine reproductive and respiratory syndrome virus
(PRRSV) emerged in the late 1980s in both Europe and
North America as the causative agent of porcine repro-
ductive and respiratory syndrome (PRRS), characterized by
late-term abortions and stillbirths in sows and interstitial
pneumonia in nursery pigs (Collins et al., 1992; Keffaber,
1989; Paton et al., 1991; Wensvoort et al., 1991). Now,
PRRS has increased in virulence, causing widespread
mortality in late-gestation sows and growing pigs of all
ages; it is the most important disease of swine worldwide
(Neumann et al., 2005; Zhou & Yang, 2010).
PRRSV is an arterivirus, a family of positive-sense, single-
stranded RNA viruses that includes: equine arteritis virus
(EAV), first isolated in 1957 (Bryans et al., 1957); lactate
dehydrogenase elevating virus of mice, isolated in 1963
(Rowson et al., 1963); and simian hemorrhagic fever virus,
first identified in 1968 (Tauraso et al., 1968). The arteriviral
RNA is 59 capped and 39 polyadenylated with two large
ORFs, 1a and 1b, which encode non-structural proteins,
followed by structural protein ORFs at the 39 end of the
genome (Snijder & Meulenberg, 1998). Structural proteins
are translated from a nested 39-coterminal set of sub-
genomic mRNAs possessing a common leader derived
from the 59 end of the genome (Faaberg, 2008). An
additional structural protein, E, is translated from an
alternative ORF embedded within ORF2 (Wu et al., 2001).
Despite extensive characterization of PRRSV structural and
non-structural proteins by direct analysis, and comparison
with other arteriviruses, the PRRSV determinants of
virulence, cellular and tissue pathogenesis, and protective
immune recognition remain poorly understood (Dokland,
2010; Faaberg, 2008; Snijder & Meulenberg, 1998). We
hypothesized that additional ORFs are present in the
PRRSV genome, whose protein products contribute to the
biological properties of PRRSV. Since we were primarily
interested in potential structural proteins, we screened
highly purified virions for evidence of novel polypeptides.
A novel 51 aa polypeptide was discovered by mass spec-
trometry. Surprisingly, it is encoded in an alternative
reading frame of subgenomic mRNA 5 (sgmRNA5), which
precedes the initiation site of the major envelope glyco-
protein, GP5. The ORF, whose product is referred to here
as ORF5a protein, is present as an alternative reading frame
of sgmRNA5 in all PRRSV and all other arteriviruses,
A supplementary table of primer sequences is available with the online
version of this paper.
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ranging in size from 43 to 64 aa.
RESULTS
Identification of a novel structural protein
Initially, PRRSV virions were purified by commonly used
methods involving rate-zonal centrifugation in sucrose (de
Limaetal., 2009; Yuan etal.,2004).Liquidchromatography–
tandem mass spectrometry (LC–MS/MS) revealed the
presence of peptide sequences identical to the predicted
tryptic peptides of a putative 51 aa protein encoded in
sgmRNA5. However, the origin of the peptide could not be
ascertained, since a wide range of non-structural proteins,
indicative of cellular protein contamination, were also
identified. Polyethylene glycol precipitation of clarified cell-
culture supernatants at 48 h after PRRSV infection, followed
by centrifugation through a sucrose cushion and isopycnic
banding twice in caesium chloride (CsCl), resulted in the
presence of a single virion population at a density of
1.22±0.1 g ml
21 (Fig. 1a). This band possessed the peak of
biologicalinfectivity,genomic RNA, subgenomic mRNAand
heteroclite RNA (Fig. 1b). The abundance of subgenomic
RNA and heteroclite mRNA was 100–1000-fold less than for
genomic RNA, indicating that PRRSV assembles predomi-
nantly one type of infectious virion containing genomic
RNA. Non-structural proteins were not present in any
preparation, indicating that cellular proteins not specifically
associated with virions had been removed quantitatively and
that the purification procedure yielded viral particles in
amounts sufficient for physical characterization.
iTRAQ (Applied Biosystems) analysis of four independently
isolated virion preparations demonstrated, in every case, the
same tryptic peptides that were previously observed in the
crude virion preparation (Fig. 2). These tryptic peptides are
encoded within a 156 nt alternative reading frame of
sgmRNA5, hereafter referred to as ORF5a, and strongly
suggest the presence of a novel51 aa structuralpolypeptide in
the virion. ORF5a precedes ORF5, which encodes GP5, by
10 nt (Fig. 3). Western blotting of ultrapurified virions with
anti-ORF5a protein antisera raised in goat against the
recombinant protein showed the presence of ORF5a protein
migrating at the same rate as in infected cell lysates (Fig. 4).
The protein migrated in the acrylamide gel with an apparent
mobility of approximately 10 kDa, even though its predicted
molecular mass is 5926 Da. Recombinant ORF5a protein
with myc and histidine tags also migrates slowly relative to its
molecular mass of 9228 Da (Fig. 4b). At higher virion protein
loadings, ORF5a protein appears as a doublet and a slightly
higher molecular mass band is also present, suggesting that
ORF5a protein may be post-translationally modified.
ORF5a protein expression in PRRSV-infected cells
To gain more information about ORF5a protein, its
kinetics of expression were determined following PRRSV
infection of MARC-145 cells. As shown in Fig. 4, Western
blotting revealed a faint chemiluminescent band at 24–48 h
after infection. Immunofluorescent staining of infected
Fig. 1. Physical characterization of PRRSV. (a) Banded PRRSV after centrifugation in CsCl. One millilitre fractions (layers) were
collected, and numbered from the top of the gradient. Fraction densities and infectivities after dialysis are shown to the right. (b)
Distribution of genomic, subgenomic and two heteroclite RNAs in the gradient. Dashed lines indicate the RT-PCR assay limit of
detection (Ct538).
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the staining was perinuclear, with or without a punctate
cytoplasmic pattern at or near the plasma membrane (Fig.
5). The staining pattern was distinct from the cytoplasmic
distribution of nucleocapsid (Fig. 5).
Induction of anti-ORF5a protein antibody
responses in pigs infected with PRRSV
To determine if ORF5a protein was expressed during
PRRSV infection of pigs, we tested for the presence of an
anti-ORF5a-protein antibody response following infection.
As shown in Fig. 6, specific antibodies were detected
4 weeks after infection and reached a plateau at about
7 weeks. The magnitude of the response was similar to that
of anti-nsp4 antibodies, which also appear relatively late
after infection and are a minor component of the anti-
PRRSV humoral immune response compared with a range
of other viral proteins.
DISCUSSION
Discovery of a novel structural protein
The 39 terminus of the PRRSV genome, in addition to
encoding known structural proteins, also contains approxi-
mately 20 potential polypeptide-encoding regions of 20 aa
or more. Of these, peptides corresponding exactly to an
alternative ORF encoding 51 aa in sgmRNA5 were present
in several independently purified viral preparations. Cloning
and sequencing of leader–body junctions of sgmRNA
showed that the VR2332 sgmRNA5 would be expected to
translate to GP5 or ORF5a protein (Nelsen et al., 1999). The
ORF5a protein initiator AUG codon is upstream of the
consensus ORF5 AUG by 10 nt, with a second AUG
representing a potential alternative ORF5a protein trans-
lation start site 11 nt downstream of the ORF5 start codon.
The second AUG in the ORF5a protein is unlikely to initiate
translation, since it is not conserved in PRRSV and is
predictedtolieatthemembranesurface(Fig.7).Becausethe
ORF5a protein initiator AUG appears first in sgmRNA5,
ORF5a protein would be expected to be expressed at an
appreciable level. The apparently low level of ORF5a protein
expression suggests that ORF5, encoding GP5, is favoured as
the start site of translation. The basis for this preferential
expression of GP5 is not clear, since neither its initiator
codon nor the two AUG sequences in ORF5b resemble the
canonical Kozak sequence that typifies eukaryotic trans-
lational start sites (Kozak, 1987).
ORF5a protein sequence analysis
PRRSV VR2332 ORF5a protein is predicted to be a type I
membrane protein consisting primarily of alpha helix with
a membrane-spanning domain (Fig. 7a) (Hirokawa et al.,
1998; Ka ¨ll et al., 2007; Rost et al., 2004). There are two
adjacent cysteine residues at positions 29 and 30, at the
interior edge of the predicted transmembrane region (Fig.
7). They might allow for disulfide linkages to form in order
to assist in oligomerization with other ORF5a protein
monomers or with other proteins produced by the virus
(Michelson, 2004; Wootton & Yoo, 2003). ORF5a protein
has a highly conserved basic RQ-rich motif near the
carboxyl terminus. Protein annotation by homology,
domain analysis and secondary structure elements did
not reveal features or motifs characteristic of known
protein families (del Val et al., 2007).
The C terminus of PRRSV ORF5a protein varies in length
owing to the presence or absence of a 5 aa truncation,
QLDAM, because of a cytosineAuracil transition that
introduces a stop codon. Since the presence or absence of
QLDAM is not correlated with any biological or
phylogenetic property we are aware of, it might be
dispensable to ORF5a protein function. An amino-
terminal 4 aa insertion is present in cell culture passage
80 of a highly virulent Chinese PRRSV isolate, JXA-1, that
is upstream of GP5 but maintains the ORF5a protein ORF,
indicating that the length of the predicted ectodomain
region may not be important to ORF5a protein function
(Han et al., 2009).
The ORF5a protein ORF is present in a wide variety of
ancient and recent type 1 and type 2 PRRSV isolates (Fig.
7b). The phylogenetic organization into three clusters is
consistent with the evolutionary divergence of type 1 and
type 2 PRRSV, and the possible extinction of wild-type
PRRSV isolates genetically related to strain VR2332, the
prototype type 2 PRRSV (Shi et al., 2010). The strain PL97-
1, isolated in 2004, is, based on sequence similarity, most
probably a field reisolate of the Ingelvac MLV vaccine. It is
notable that the conserved RQ-motif of ORF5a protein is
encoded by the same RNA sequence that encodes the
hypervariable glycosylation-rich ectodomain region of GP5
(Fig. 3b, boxed region) (Kapur et al., 1996). Interestingly,
PRRSV contains another genomic region encoding ORF3,
large parts of which also encode ORF2 and ORF4 (Meng
et al., 1995; Murtaugh et al., 1995). This propensity for
maintaining functionally intact, overlapping ORFs for
essential viral structural proteins in the presence of high
levels of nucleotide sequence diversity is an exceptional
feature of PRRSV.
Universal presence of the ORF5a protein ORF in
PRRSV and arteriviruses
A predicted ORF5a protein highly similar to that encoded
in the genome of VR2332 is present in all arteriviruses. The
amino acid length varies from 46 to 51 in type 2 PRRSV, 43
in type 1 PRRSV, and from 47 to 64 in the other
arteriviruses (Fig. 7). All of the predicted proteins contain
an amino-terminal MF sequence, equivalent membrane
topologies and R/Q-rich endodomain features (Fig. 7a). R
and R/Q-rich motifs are involved in RNA binding that can
regulate mRNA splicing and transport (Bayer et al., 2005;
Novel arterivirus structural protein
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sequence of GP5 and the alternative ORF5a encoding the ORF5a protein. Shaded regions are the tryptic peptides identified by MS/MS sequencing. Boxed region shows the
conserved R/Q-rich sequence.
Fig. 2. MS/MS sequencing of ORF5a-protein tryptic peptides. Peptide marked by red shading was identified in one sample (a). Peptide marked by blue shading was observed
in three independent repetitions of the experiment (b–d). Spectra histogramas are shown to the left. Fragment ion tables are shown to the right. Amino acid sequences are in
the column marked ‘AA’.
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1Tan & Frankel, 1998), suggesting a possible role for the
ORF5a protein. Mutational inactivation of ORF5a in EAV
severely impaired replication, showing that maintenance of
intact ORF5a is important for viability (Firth et al., 2011).
Thus, the ORF5a protein is not a happenstance sequence
but represents a highly conserved ORF present throughout
the family Arteriviridae whose function is not yet known,
but may be related to efficient arteriviral RNA processing,
transport or packaging.
The appearance of anti-ORF5a protein antibodies in swine
following PRRSV infection shows that ORF5a protein
expression is an intrinsic part of the PRRSV life cycle in
vivo. The kinetics of antibody production show a slow
appearance similar to that previously observed for anti-
GP5 antibodies, and are consistent with the time course of
neutralizing antibody production (Molina et al., 2008;
Mulupuri et al., 2008). The low level of antibody
expression is consistent with low levels of ORF5a protein
synthesis and supports in vitro data indicating that it is
present in low levels in infected cells and in virions. It is
also possible that the ORF5a protein elicits a predomi-
nantly cell-mediated immune response rather than a
humoral response (Jeong et al., 2010).
Discovery of a novel structural protein, ORF5a protein, in
PRRSV is supported by direct mass spectrometric evidence in
purified virions, expression of the protein in cultured cells
infected with PRRSV and induction of a specific immune
Fig. 4. Immunoblot analysis of ORF5a protein. (a) Lysates of
MARC 145 cells infected (+) or not infected (–) with PRRSV
strain VR2332 were electrophoresed in an SDS-polyacrylamide
gel and immunoblotted with goat anti-ORF5a protein antiserum.
Specific anti-ORF5a protein staining is observed at time points
after 20 h of infection; C, positive control sample of recombinant
ORF5a protein, molecular mass 9.2 kDa. (b) ORF5a protein
detection in purified virions by immunoblotting. Amount of viral
protein loaded in lanes ranged from 0.1 to 1 mg as indicated.
Lanes +48 and –48 represent lysates of cells incubated for 48 h
with (+) or without (–) PRRSV. C, control recombinant ORF5a
protein (9.2 kDa) as in (a). M, Kaleidoscope standards aprotinin
(7.6 kDa) and lysozyme (18.4 kDa) (Bio-Rad).
Fig. 5. Immunofluorescent localization of ORF5a protein in PRRSV-infected MARC 145 cells. Cells were fixed at 0, 6, 12 and
24 h after infection (columns) and stained with fluorescein-labelled anti-nucleocapsid antibody (anti-N), goat anti-ORF5a protein
antiserum immunodepleted to remove anti-myc antibodies (anti-ORF5a), and negative-control second antibody alone (C).
C. R. Johnson and others
1112 Journal of General Virology 92response in infected pigs. A unique feature of the protein is its
expression from an alternative ORF upstream of the highly
expressed GP5 in sgmRNA5. It appears to be present in cells
andvirionsat alowlevel,suggestingthepresenceofstructural
features in sgmRNA5 that do not favour translation from the
first AUG. Its discovery provides a new potential target for
immunological and pharmacological intervention in PRRS,
the most important disease of swine worldwide.
METHODS
Viruses. The PRRSV isolate VR-2332 (GenBank number PRU87392)
was propagated in MARC 145 cells maintained in EMEM medium
(Invitrogen Life Technologies) containing 10% FBS (Kim et al.,
1993). For large-scale preparation, cells in 75 cm
2 flasks were infected
at variable m.o.i. and incubated at 37 uCi na5%C O 2 atmosphere.
Infected cell supernatant was harvested at 48 h after infection, before
a cytopathic effect was observed (Yuan et al., 2001). Cellular debris
was removed by centrifugation at 3800 g at 4 uC for 30 min.
Supernatant was collected and polyethylene glycol 8000 (PEG 8000;
Fisher Scientific) was added to a final concentration of 10% (w/v)
and stirred gently overnight at 4 uC. Precipitated proteins were
collected by centrifugation at 17700 g for 1 h at 4 uC. The pellet was
resuspended in 50 mM HEPES, 100 mM NaCl, 1 mM EDTA, pH 7.5.
The sample was carefully layered onto a cushion of 0.5 M sucrose in
10 mM NaCl, 10 mM Tris/HCl, 1 mM EDTA (STE), pH 7.5, in SW
32 Ti ultracentrifuge tubes (Beckman Coulter). Virus was pelleted at
110000 g at 4 uC for 3 h. Pellets were collected, resuspended and
pelleting was repeated once.
Pellets were resuspended in 1.25 g ml
21 CsCl, 50 mM HEPES,
100 mM NaCl, 1 mM EDTA at pH 7.5 and centrifuged in a type 70.1
Ti rotor at 247000 g (Beckman Coulter) for 72 h. Viral bands and
density-gradient aliquots were carefully extracted by syringe.
Equilibrium density-gradient centrifugation was repeated one further
time. Purified virions were dialysed against 50 mM HEPES, 100 mM
NaCl, 1 mM EDTA, pH 7.5, at 4 uC with several buffer exchanges.
CsCl layers were examined by refractive index (American Digital),
quantitative RT-PCR (qRT-PCR) for viral RNA levels (Applied
Biosystems) and TCID50 on MARC 145 cells.
Viral RNA isolation and qRT-PCR. Viral RNA was isolated using a
QIAamp Viral RNA Mini kit (Qiagen) or a Nucleospin II RNA
Isolation kit (BD Biosciences), eluted into 50 ml of RNase-free water,
and stored at 280 uC. Complementary DNA was synthesized with
Superscript II reverse-transcriptase (Invitrogen Life Technologies).
Primers shown in Supplementary Table S1 (available in JGV Online)
were selected to span the appropriate region of the viral genome to
identify specific populations of RNA, including heteroclite RNA,
using PRIMER3 software (Rozen & Skaletsky, 2000). Heteroclite RNA
contains 59 and 39 genomic fragments with non-canonical leader–
body junctions, similar to defective interfering RNA described in
coronaviruses, but it does not interfere with growth (Yuan et al.,
2000). Primers were mixed with sample and 26 SYBR Green
MasterMix (Perkin-Elmer Applied Biosystems). Quantitative RT-PCR
was carried out with an ABI 7500 Sequence Detection System
(Perkin-Elmer Applied Biosystems). Thermocycling conditions were
95 uC for 10 min, followed by 45 cycles of 95 uC for 15 s and 60 uC
for 1 min (Baker et al., 2007).
Expression of recombinant ORF5a protein and anti-ORF5a
protein IgG production. Recombinant ORF5a protein containing an
amino terminal myc tag (MEQKLISEEDL) and a carboxyl terminal 6 6
histidine tag (LEHHHHHH) was cloned and expressed in Escherichia
coli Rosetta 2(DE3) cells (Novagen) as previously described (Johnson
et al., 2007). Protein was purified using an Ni-NTA spin column
(Qiagen) or HisPur Cobalt Resin (Pierce). ORF5a protein expression
amounts and purity were monitored by SDS-PAGE. Purified
recombinant ORF5a protein was sent to Bethyl Laboratories
(Montgomery TX, USA) for antibody production in a goat.
Affinity purification of anti-ORF5a protein antibodies.
Recombinant ORF5a protein and control porcine haptoglobin a1S,
also containing myc and histidine tags and expressed and purified in
the same way as ORF5a protein, were immobilized on CNBr-activated
Sepharose 4B (GE Healthcare) according to the manufacturer’s
instructions (Gnanandarajah et al., 2008; Johnson et al., 2007).
Affinity columns were stored at 4 uC in 20% ethanol (v/v) after
ligand coupling.
Anti-myc antibodies were removed on the haptoglobin a1S-
Sepharose column, and anti-ORF5a-protein antibodies were purified
from anti-myc-depleted serum on ORF5a protein–Sepharose. Sera
were passed through a 0.45 mm filter and then passed through the
affinity column by gravity flow twice. Removal or concentration of
specific antibodies was monitored by ELISA as described by Johnson
et al. (2007).
Western blot analysis. Protein samples were electrophoresed in
10% SDS-polyacrylamide gels and transferred to PVDF membranes
(Immobilon-P; Millipore). Membranes were blocked in 5% non-fat
dry milk and 0.1% Tween-20 (Sigma) in PBS (pH 7.4) overnight.
Membranes were incubated with sera for 1 h at room temperature,
washed, and incubated with HRP-labelled rabbit anti-goat IgG (KPL)
at a 1:2000 dilution at room temperature. Enhanced chemilumin-
escence Western blotting detection reagents were used according to
the manufacturer’s instructions (Thermo Fisher Scientific) to
visualize the bands.
Fig. 6. Kinetics of anti-ORF5a protein antibody
response in pigs infected with PRRSV strain
VR2332. Antibodies were first detected at
28 days after infection and reached a plateau
at 42 days. Antibody responses to nsp4, nsp2
fragment P (nsp2P), nucleocapsid (N) and
nsp7 also are shown for comparison. Data are
mean±1 SEM, n510 in all cases.
Novel arterivirus structural protein
http://vir.sgmjournals.org 1113Fig. 7. Comparison of ORF5a proteins in the Arteriviridae. (a) Topological prediction of ORF5a protein in type 1 and type 2
PRRSV, LDV, EAV and SHFV. Model predictions were performed in SOSUI (Hirokawa et al., 1998). Conserved amino-terminal
MF sequence and endodomain R and Q residues are highlighted in grey. (b) Phylogenetic analysis of ORF5a protein in the
family Arteriviridae. Isolates are identified by common name, year of isolation, and GenBank accession number of the genome
sequence. Major type 1 and type 2 PRRSV clusters are noted. Amino acid sequences were aligned in CLUSTAL X and a tree was
constructed using neighbour joining and bootstrap analysis with 10000 resamples. The tree was drawn in FigTree version
1.2.3. The shaded region shows the conserved R/Q-rich domain.
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cells were grown for two days on glass coverslips and then infected
with PRRSV strain VR2332 overnight. Coverslips were washed in PBS
(pH 7.4), and cells were fixed in 80% acetone, 20% methanol at 4 uC
for 20 min, followed by three washes in PBS. Coverslips were blocked
in 1% BSA in PBS for 1 h at 37 uC. Goat anti-ORF5a-protein
antiserum depleted of anti-myc antibodies by affinity chromato-
graphy was diluted 1:1000 in 1% BSA and centrifuged at 13200 g
for 10 min to remove fine particulates, then applied to each coverslip
for 1 h at 37 uC. Coverslips were washed 3 times in PBS and 100 mlo f
Alexa Fluor 488-labelled rabbit anti-goat IgG, diluted 1:2000 in 1%
BSA, was added for 45 min at 37 uC, followed by 3 washes in PBS.
Fluorescein-labelled SDOW17 anti-nucleocapsid mAb (Rural
Technologies) was used as a positive control. Cell nuclei were stained
with 0.1 mg bisbenzimide ml
21 for 10 min at room temperature
during the final wash. Excess moisture was blotted away and
coverslips were mounted on clean glass slides. Immunofluorescence
was observed by using an MRC 1024 laser confocal microscope
(Nikon Diaphot Inverted; Bio-Rad) at 408 nm, 488 nm and 555 nm
excitation frequencies.
Micro liquid chromatography–pulsed Q collision induced
dissociation (mLC–PQD) MS/MS. An automated Paradigm MS4
system (Michrochrom Bioresources) was used inline with an LTQ
mass spectrometer (ThermoFisher) as previously described (Xie et al.,
2007). Buffer A was 0.1% formic acid in a solution of 95%
acetonitrile and 5% water. Peptides were eluted using a linear
gradient of 10 to 35% HPLC buffer B (0.1% formic acid in a solution
of aqueous 95% acetonitrile) over 1 h followed by an isocratic elution
at 80% buffer B for 5 min (flow rate 0.25 ml min
21).
mLC-quadrapole time-of-flight (TOF) mass spectrometry. An
Online LC system (LC Packings/Dionex) was used on a QSTAR
Pulsar i quadrapole-TOF MS instrument (ABI, Foster City, CA)
equipped with a nanoelectrospray source (Protana, Denmark)
(Kapphahn et al., 2003). A qTOF MS electrospray ionization
voltage of 1000 V was used, with a TOF region acceleration voltage
of 4 kV and an injection pulse repetition rate of 6.0 kHz.
Calibrations were performed using the [M+3H]
3+ at 586.9830
mass/charge (m/z) monoisotopic peak and the [M+2H]
2+ mono-
isotopic peak at 879.9705 m/z from human renin substrate
tetradecapeptide (Sigma-Aldrich).
MALDI mass spectrometry. Samples were desalted using a C18
ZipTip (Millipore). One microlitre of sample was combined with 1 ml
of matrix dihydroxybenzoic acid (Agilent Technologies), spotted onto
the target, and air-dried. Data were collected on a Biflex III MALDI-
TOF mass spectrometer (Bruker Daltonics) operated in linear mode
as described previously (Gnanandarajah et al., 2008; Nelsestuen et al.,
2005) and an oMALDI-Qstar Pulsar i QqTOF mass spectrometer
(ABI). Angiotensin II (monoisotopic mass [M+H]
+1 1046.5417
(Sigma-Aldrich) and adrenocorticotropic hormone (ACTH) frag-
ment 18–39 (monoisotopic mass [M+H]
+1 2465.1989; Sigma
Aldrich) were used for calibration. A nitrogen laser (337 nm, 33 mJ)
with pulse repetition rate of 20 Hz was used and mean mass spectra
were taken from 100 laser shots in positive mode.
LTQ-PQD data analysis. The SEAQUEST program (Bioworks version
3.2; Thermo Fisher) was used to search against a composite database
consisting of all VR2332 ORFs .25 aa and a subset of monkey, pig
and random contaminates from the NCBI (http://www.ncbi.nlm.nih.
gov) non-redundant protein database of 15 May 2006. Search
parameters included differential amino acid shifts for oxidized
methionine ( +16 Da) allowing for up to two partially missed internal
tryptic peptides. Peptide tolerances were ±150 p.p.m. and MS/MS
tolerance of ±0.40 Da was allowed.
QSTAR data analysis. Protein Pilot version 1 (ABI) and MASCOT
(Matrix Science) were used to analyse the data with the previously
mentioned composite database. A generic set of variable amino acid
modifications were used that included oxidized methionine and
modifications for lysine, tyrosine and peptide amino-termini.
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